Status:
UNKNOWN
Nebulized hypErtonic Saline for Better Prevention of mUcus pLug in Critical Adult Tracheostomized Patients
Lead Sponsor:
Hospital Universitario Virgen de la Arrixaca
Conditions:
Critical Illness
Tracheostomy Complication
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Tracheostomy is an important tool in the management of respiratory failure in the critically ill patient under mechanical ventilation. Although mechanical ventilation can be a lifesaving intervention,...
Eligibility Criteria
Inclusion
- Age \>= 18 years.
- Respiratory support through tracheostomy performed during ICU stay.
- Informed consent signed by the relatives or legal representative of the patient.
Exclusion
- Pregnancy.
- Any terminal disease.
- Known hypersensitivity to any component of Hyaneb (Hypertonic saline of NaCl (7%) in combination with hyaluronic acid).
- Participation in another research study.
- Any other condition that, according to the investigator, may prevent a participant to complete all the procedures required.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT03870646
Start Date
April 1 2019
End Date
December 31 2020
Last Update
March 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain, 30120